SLE(SLE)
SLE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $15M | $22M |
| Low | $14M | $21M |
| High | $15M | $23M |
| EBITDA Avg | $-14M | $-21M |
| Low | $-14M | $-21M |
| High | $-13M | $-20M |
| EBIT Avg | $-15M | $-22M |
| Low | $-15M | $-22M |
| High | $-14M | $-21M |
| Net Income Avg | $-224,324 | $-154,479.5 |
| Low | $-232,747 | $-160,280 |
| High | $-215,901 | $-148,679 |
| EPS Avg | $-5.46 | $-3.76 |
| Low | $-5.67 | $-3.90 |
| High | $-5.26 | $-3.62 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $3M | $5M |
| Low | $3M | $5M |
| High | $3M | $5M |
| EBITDA Avg | $-3M | $-4M |
| Low | $-3M | $-5M |
| High | $-3M | $-4M |
| EBIT Avg | $-3M | $-5M |
| Low | $-3M | $-5M |
| High | $-3M | $-5M |
| Net Income Avg | $-3M | $-3M |
| Low | $-3M | $-3M |
| High | $-3M | $-2M |
| EPS Avg | $-1.25 | $-1.03 |
| Low | $-1.27 | $-1.05 |
| High | $-1.23 | $-1.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |